Sign Up Today and Learn More About Hims Stock

Invest in or calculate the value of your shares in Hims or other pre-IPO companies through EquityZen's platform.

Get Started

Hims Stock

Men's wellness brand

About Hims Stock




San Francisco, CA, US

Notable Investor

Forerunner Ventures

Total Funding


Hims is an e-commerce wellness brand made for men with products for skin care, erectile dysfunction, and hair loss. The company works with doctors to prescribe Finasteride and Sildenafil (active ingredient in Viagra) through the app or website. With a telemedicine approach, hims allows customers to get diagnosed and treated at a lower cost and with greater convenience. Hims was incubated at San Francisco-based venture-builder, Atomic. In November 2017, the company raised $7 million in Series A funding from Thrive Capital, Forerunner Ventures, M.C. Ventures, SV Angel, Amity Supply, and Harry’s. In June 2018, hims raised $50 million in Series B funding. Institutional Venture Partners led the round which included Forerunner Ventures, Thrive Capital, Maverick Capital, and Redpoint Ventures. Hims was founded in November 2017 after CEO Andrew Dudum was called out by his sister for having dry skin and breakouts. She ordered him a bunch of expensive products to help fix the issues and Dudum quickly realized that men didn’t have the same options as women when it came to purchasing wellness products. He set out to create a company that offered simple solutions for issues many guys face. In November 2017 hims was launched and nearly four months after it was reported that the company was worth $200 million.

Investors in Hims

Discover investors in Hims stock and explore their portfolio companies

Hims Management

Leadership team at Hims

Co-Founder & Chief Executive Officer

Andrew Dudum

Co-Founder & VP Product

Hilary Coles

Locked Features

Join now and verify your accreditation status to gain access to:

  • Hims current valuation
  • Hims stock price
  • Available deals in Hims and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Hims stock?

Accredited investors can buy pre-IPO stock in companies like Hims through EquityZen funds. These investments are made available by existing Hims shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Hims stock?

Shareholders can sell their Hims stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."